Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Beijing Tiantan MMR vaccine
- Development stage
- Unknown
- Lead developer
- Chinese Center for Disease Control and Prevention
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Beijing Tiantan MMR vaccine is a live attenuated trivalent vaccine designed to prevent measles, mumps, and rubella. Developed under the oversight of the Chinese Center for Disease Control and Prevention and manufactured by Beijing Tiantan Biological Products, the vaccine is a freeze-dried powder formulation administered via injection. It contains live attenuated strains of the measles virus, mumps virus, and rubella virus, which stimulate the host's immune system to produce protective antibodies and cellular immunity. This vaccine is a core component of China's National Immunization Program and is routinely administered to children between 18 months and 6 years of age.
- Other names
- measles, mumps and rubella combined vaccine, live-Centers for Disease Control and Prevention, China-measles-mumps-rubellaMeasles, mumps and rubella Combined Vaccine, LiveBeijing Tiantan MMR vaccine
Beyond the preview
Go deeper on Beijing Tiantan MMR vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Tiantan MMR vaccine.